Alibaba Group will shift its Tmall online-pharmacy business to its publicly traded health-care arm in a deal valued at $2.51 billion, as it ramps its focus in that sector.
read more
Alibaba Group will shift its Tmall online-pharmacy business to its publicly traded health-care arm in a deal valued at $2.51 billion, as it ramps its focus in that sector.
read more